Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Vancampfort, D.; Mitchell, A.J.; De Hert, M.; Sienaert, P.; Probst, M.; Buys, R.; Stubbs, B. Prevalence and predictors of type 2 diabetes mellitus in people with bipolar disorder: A systematic review and meta-analysis. J. Clin. Psychiatry 2015, 76, 1490–1499. [Google Scholar] [CrossRef]
- McIntyre, R.S.; Konarski, J.Z.; Misener, V.L.; Kennedy, S.H. Bipolar disorder and diabetes mellitus: Epidemiology, etiology, and treatment implications. Ann. Clin. Psychiatry 2005, 17, 83–93. [Google Scholar] [CrossRef]
- Vancampfort, D.; Correll, C.U.; Galling, B.; Probst, M.; De Hert, M.; Ward, P.B.; Rosenbaum, S.; Gaughran, F.; Lally, J.; Stubbs, B. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: A systematic review and large scale meta-analysis. World Psychiatry 2016, 15, 166–174. [Google Scholar] [CrossRef]
- Calkin, C.V.; Ruzickova, M.; Uher, R.; Hajek, T.; Slaney, C.M.; Garnham, J.S.; O’Donovan, M.C.; Alda, M. Insulin resistance and outcome in bipolar disorder. Br. J. Psychiatry 2015, 206, 52–57. [Google Scholar] [CrossRef] [Green Version]
- Mansur, R.B.; Rizzo, L.B.; Santos, C.M.; Asevedo, E.; Cunha, G.R.; Noto, M.N.; Pedrini, M.; Zeni, M.; Cordeiro, Q.; McIntyre, R.S.; et al. Impaired glucose metabolism moderates the course of illness in bipolar disorder. J. Affect. Disord. 2016, 195, 57–62. [Google Scholar] [CrossRef]
- Guha, P.; Bhowmick, K.; Mazumder, P.; Ghosal, M.; Chakraborty, I.; Burman, P. Assessment of insulin resistance and metabolic syndrome in drug naive patients of bipolar disorder. Indian J. Clin. Biochem. 2014, 29, 51–56. [Google Scholar] [CrossRef] [PubMed]
- Tabak, A.G.; Jokela, M.; Akbaraly, T.N.; Brunner, E.J.; Kivimaki, M.; Witte, D.R. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: An analysis from the Whitehall II study. Lancet 2009, 373, 2215–2221. [Google Scholar] [CrossRef]
- Isomaa, B.; Almgren, P.; Tuomi, T.; Forsen, B.; Lahti, K.; Nissen, M.; Taskinen, M.R.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24, 683–689. [Google Scholar] [CrossRef] [PubMed]
- Cairns, K.; McCarvill, T.; Ruzickova, M.; Calkin, C.V. Course of bipolar illness worsens after onset of insulin resistance. J. Psychiatr. Res. 2018, 102, 34–37. [Google Scholar] [CrossRef]
- Baker, L.D.; Cross, D.J.; Minoshima, S.; Belongia, D.; Watson, G.S.; Craft, S. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch. Neurol. 2011, 68, 51–57. [Google Scholar] [CrossRef] [PubMed]
- Willette, A.A.; Bendlin, B.B.; Starks, E.J.; Birdsill, A.C.; Johnson, S.C.; Christian, B.T.; Okonkwo, O.C.; La Rue, A.; Hermann, B.P.; Koscik, R.L.; et al. Association of Insulin Resistance with Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease. JAMA Neurol. 2015, 72, 1013–1020. [Google Scholar] [CrossRef]
- Hajek, T.; Calkin, C.; Blagdon, R.; Slaney, C.; Uher, R.; Alda, M. Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders. Neuropsychopharmacology 2014, 39, 2910–2918. [Google Scholar] [CrossRef]
- Hajek, T.; Calkin, C.; Blagdon, R.; Slaney, C.; Alda, M. Type 2 diabetes mellitus: A potentially modifiable risk factor for neurochemical brain changes in bipolar disorders. Biol. Psychiatry 2015, 77, 295–303. [Google Scholar] [CrossRef]
- Calkin, C.V.; Alda, M. Insulin resistance in bipolar disorder: Relevance to routine clinical care. Bipolar Disord. 2015, 17, 683–688. [Google Scholar] [CrossRef]
- Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346, 393–403. [Google Scholar]
- Fernandez-Berges, D.; Felix-Redondo, F.J.; Lozano, L.; Perez-Castan, J.F.; Sanz, H.; Cabrera De Leon, A.; Hidalgo, A.B.; Morcillo, Y.; Tejero, V.; Alvarez-Palacios, P. Prevalence of metabolic syndrome estimated with the new World Health Organization recommendations. The HERMEX study. Gac. Sanit. 2011, 25, 519–524. [Google Scholar]
- Lee, S.H.; Kwon, H.S.; Park, Y.M.; Ha, H.S.; Jeong, S.H.; Yang, H.K.; Lee, J.H.; Yim, H.W.; Kang, M.I.; Lee, W.C.; et al. Predicting the development of diabetes using the product of triglycerides and glucose: The Chungju Metabolic Disease Cohort (CMC) study. PLoS ONE 2014, 9, e90430. [Google Scholar] [CrossRef]
- World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation; World Health Organization: Geneva, Switzerland, 2006. [Google Scholar]
- American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42, S13–S28. [Google Scholar] [CrossRef]
- Ascaso, J.F.; Pardo, S.; Real, J.T.; Lorente, R.I.; Priego, A.; Carmena, R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003, 26, 3320–3325. [Google Scholar] [CrossRef]
- DeFronzo, R.A.; Tobin, J.D.; Andres, R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am. J. Physiol. 1979, 237, E214–E223. [Google Scholar] [CrossRef]
- Antuna-Puente, B.; Disse, E.; Rabasa-Lhoret, R.; Laville, M.; Capeau, J.; Bastard, J.P. How can we measure insulin sensitivity/resistance? Diabetes Metab. 2011, 37, 179–188. [Google Scholar] [CrossRef]
- Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412–419. [Google Scholar] [CrossRef]
- Bonora, E.; Targher, G.; Alberiche, M.; Bonadonna, R.C.; Saggiani, F.; Zenere, M.B.; Monauni, T.; Muggeo, M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23, 57–63. [Google Scholar] [CrossRef]
- Radikova, Z.; Koska, J.; Huckova, M.; Ksinantova, L.; Imrich, R.; Vigas, M.; Trnovec, T.; Langer, P.; Sebokova, E.; Klimes, I. Insulin sensitivity indices: A proposal of cut-off points for simple identification of insulin-resistant subjects. Exp. Clin. Endocrinol. Diabetes 2006, 114, 249–256. [Google Scholar] [CrossRef]
- Simental-Mendia, L.E.; Rodriguez-Moran, M.; Guerrero-Romero, F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 2008, 6, 299–304. [Google Scholar] [CrossRef]
- Guerrero-Romero, F.; Simental-Mendia, L.E.; Gonzalez-Ortiz, M.; Martinez-Abundis, E.; Ramos-Zavala, M.G.; Hernandez-Gonzalez, S.O.; Jacques-Camarena, O.; Rodriguez-Moran, M. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 2010, 95, 3347–3351. [Google Scholar] [CrossRef]
- Mazidi, M.; Kengne, A.P.; Katsiki, N.; Mikhailidis, D.P.; Banach, M. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance. J. Diabetes Complicat. 2018, 32, 266–270. [Google Scholar] [CrossRef]
- Kang, B.; Yang, Y.; Lee, E.Y.; Yang, H.K.; Kim, H.S.; Lim, S.Y.; Lee, J.H.; Lee, S.S.; Suh, B.K.; Yoon, K.H. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int. J. Obes. 2017, 41, 789–792. [Google Scholar] [CrossRef]
- Patarrão, R.; Lautt, W.W.; Macedoc, M.P. Assessment of methods and indexes of insulin sensitivity. SPEDM 2014, 9, 65–73. [Google Scholar] [CrossRef] [Green Version]
- Hanley, A.J.; Williams, K.; Gonzalez, C.; D’Agostino, R.B., Jr.; Wagenknecht, L.E.; Stern, M.P.; Haffner, S.M. Prediction of type 2 diabetes using simple measures of insulin resistance: Combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003, 52, 463–469. [Google Scholar] [CrossRef]
- Robins, S.J.; Rubins, H.B.; Faas, F.H.; Schaefer, E.J.; Elam, M.B.; Anderson, J.W.; Collins, D. Insulin resistance and cardiovascular events with low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care 2003, 26, 1513–1517. [Google Scholar] [CrossRef]
- Judd, L.L.; Akiskal, H.S.; Schettler, P.J.; Endicott, J.; Leon, A.C.; Solomon, D.A.; Coryell, W.; Maser, J.D.; Keller, M.B. Psychosocial disability in the course of bipolar I and II disorders: A prospective, comparative, longitudinal study. Arch. Gen. Psychiatry 2005, 62, 1322–1330. [Google Scholar] [CrossRef]
- Kemp, D.E.; Sylvia, L.G.; Calabrese, J.R.; Nierenberg, A.A.; Thase, M.E.; Reilly-Harrington, N.A.; Ostacher, M.J.; Leon, A.C.; Ketter, T.A.; Friedman, E.S.; et al. General medical burden in bipolar disorder: Findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr. Scand. 2014, 129, 24–34. [Google Scholar] [CrossRef]
- Bipolar Disorder: Assessment and Management. Available online: https://www.nice.org.uk/guidance/cg185 (accessed on 21 January 2019).
- Malhi, G.S.; Bassett, D.; Boyce, P.; Bryant, R.; Fitzgerald, P.B.; Fritz, K.; Hopwood, M.; Lyndon, B.; Mulder, R.; Murray, G.; et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust. N. Z. J. Psychiatry 2015, 49, 1087–1206. [Google Scholar] [CrossRef]
- Yatham, L.N.; Kennedy, S.H.; Parikh, S.V.; Schaffer, A.; Bond, D.J.; Frey, B.N.; Sharma, V.; Goldstein, B.I.; Rej, S.; Beaulieu, S.; et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018, 20, 97–170. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines; World Health Organization: Geneva, Switzerland, 1992. [Google Scholar]
- Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6, 278–296. [Google Scholar] [CrossRef]
- Young, R.C.; Biggs, J.T.; Ziegler, V.E.; Meyer, D.A. A rating scale for mania: Reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133, 429–435. [Google Scholar] [CrossRef]
- Esteghamati, A.; Ashraf, H.; Khalilzadeh, O.; Zandieh, A.; Nakhjavani, M.; Rashidi, A.; Haghazali, M.; Asgari, F. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: Third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr. Metab. 2010, 7, 26. [Google Scholar] [CrossRef] [PubMed]
- Petäjä, E.M.; Zhou, Y.; Peltonen, M.; Jouslahti, P.; Männistö, S.; Keinänen-Kiukaanniemi, S.; Saltevo, J.; Yki-Järvinen, H. Determination of a Normal value for HOMA-IR and cut-off Value for Non-Alcoholic Fatty Liver Disease. J. Hepatol. 2016, 64, S481. [Google Scholar] [CrossRef]
- Ghasemi, A.; Tohidi, M.; Derakhshan, A.; Hasheminia, M.; Azizi, F.; Hadaegh, F. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study. Acta Diabetol. 2015, 52, 905–915. [Google Scholar] [CrossRef]
- Hedblad, B.; Nilsson, P.; Janzon, L.; Berglund, G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet. Med. 2000, 17, 299–307. [Google Scholar] [CrossRef]
- Simental-Mendia, L.E.; Simental-Mendia, E.; Rodriguez-Hernandez, H.; Rodriguez-Moran, M.; Guerrero-Romero, F. The product of triglycerides and glucose as biomarker for screening simple steatosis and NASH in asymptomatic women. Ann. Hepatol. 2016, 15, 715–720. [Google Scholar]
- Cameron, N.; Bogin, B. Human Growth and Development, 2nd ed.; Academic Press: Cambridge, MA, USA, 2012. [Google Scholar]
- American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015, 38 (Suppl. 1), S8–S16. [Google Scholar] [CrossRef]
- Ruzickova, M.; Slaney, C.; Garnham, J.; Alda, M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can. J. Psychiatry 2003, 48, 458–461. [Google Scholar] [CrossRef]
- Low, S.; Khoo, K.C.J.; Irwan, B.; Sum, C.F.; Subramaniam, T.; Lim, S.C.; Wong, T.K.M. The role of triglyceride glucose index in development of Type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 2018, 143, 43–49. [Google Scholar] [CrossRef]
- Salazar, J.; Bermudez, V.; Calvo, M.; Olivar, L.C.; Luzardo, E.; Navarro, C.; Mencia, H.; Martinez, M.; Rivas-Rios, J.; Wilches-Duran, S.; et al. Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: A cross-sectional study in a Venezuelan population. F1000Research 2017, 6, 1337. [Google Scholar] [CrossRef] [Green Version]
- World Health Organization. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation, Geneva, 8–11 December 2008; WHO: Geneva, Switzerland, 2008. [Google Scholar]
- Wang, Y.; Rimm, E.B.; Stampfer, M.J.; Willett, W.C.; Hu, F.B. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am. J. Clin. Nutr. 2005, 81, 555–563. [Google Scholar] [CrossRef]
- Lee, S.H.; Han, K.; Yang, H.K.; Kim, H.S.; Cho, J.H.; Kwon, H.S.; Park, Y.M.; Cha, B.Y.; Yoon, K.H. A novel criterion for identifying metabolically obese but normal weight individuals using the product of triglycerides and glucose. Nutr. Diabetes 2015, 5, e149. [Google Scholar] [CrossRef]
- Hwang, Y.C.; Hayashi, T.; Fujimoto, W.Y.; Kahn, S.E.; Leonetti, D.L.; McNeely, M.J.; Boyko, E.J. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int. J. Obes. 2015, 39, 1365–1370. [Google Scholar] [CrossRef] [Green Version]
- Ho, R.C.M.; Chua, A.C.; Tran, B.X.; Choo, C.C.; Husain, S.F.; Vu, G.T.; McIntyre, R.S.; Ho, C.S.H. Factors Associated with the Risk of Developing Coronary Artery Disease in Medicated Patients with Major Depressive Disorder. Int. J. Environ. Res. Public Health 2018, 15, 10. [Google Scholar] [CrossRef]
- Navarro-Gonzalez, D.; Sanchez-Inigo, L.; Pastrana-Delgado, J.; Fernandez-Montero, A.; Martinez, J.A. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: The Vascular-Metabolic CUN cohort. Prev. Med. 2016, 86, 99–105. [Google Scholar] [CrossRef]
- Calkin, C.V.; Gardner, D.M.; Ransom, T.; Alda, M. The relationship between bipolar disorder and type 2 diabetes: More than just co-morbid disorders. Ann. Med. 2013, 45, 171–181. [Google Scholar] [CrossRef]
- Malhi, G.S.; Outhred, T.; Morris, G.; Boyce, P.M.; Bryant, R.; Fitzgerald, P.B.; Hopwood, M.J.; Lyndon, B.; Mulder, R.; Murray, G.; et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary. Med. J. Aust. 2018, 208, 219–225. [Google Scholar] [CrossRef]
- American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42, S90–S102. [Google Scholar] [CrossRef]
- American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42, S46–S60. [Google Scholar] [CrossRef]
- American Diabetes Association. 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42, S29–S33. [Google Scholar] [CrossRef]
- Sahin, I.; Alkan, A.; Keskin, L.; Cikim, A.; Karakas, H.M.; Firat, A.K.; Sigirci, A. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J. Diabetes Complicat. 2008, 22, 254–260. [Google Scholar] [CrossRef]
- Łojko, D.; Stelmach-Mardas, M.; Suwalska, A. Diet quality and eating patterns in euthymic bipolar patients. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 1221–1238. [Google Scholar]
- Zanuso, S.; Jimenez, A.; Pugliese, G.; Corigliano, G.; Balducci, S. Exercise for the management of type 2 diabetes: A review of the evidence. Acta Diabetol. 2010, 47, 15–22. [Google Scholar] [CrossRef]
- Palacios, O.M.; Kramer, M.; Maki, K.C. Diet and prevention of type 2 diabetes mellitus: Beyond weight loss and exercise. Expert Rev. Endocrinol. Metab. 2019, 14, 1–12. [Google Scholar] [CrossRef]
- Kemp, D.E.; Schinagle, M.; Gao, K.; Conroy, C.; Ganocy, S.J.; Ismail-Beigi, F.; Calabrese, J.R. PPAR-gamma agonism as a modulator of mood: Proof-of-concept for pioglitazone in bipolar depression. CNS Drugs 2014, 28, 571–581. [Google Scholar] [CrossRef]
- Regenold, W.T.; Thapar, R.K.; Marano, C.; Gavirneni, S.; Kondapavuluru, P.V. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 2002, 70, 19–26. [Google Scholar] [CrossRef]
- Allison, D.B.; Newcomer, J.W.; Dunn, A.L.; Blumenthal, J.A.; Fabricatore, A.N.; Daumit, G.L.; Cope, M.B.; Riley, W.T.; Vreeland, B.; Hibbeln, J.R.; et al. Obesity among those with mental disorders: A National Institute of Mental Health meeting report. Am. J. Prev. Med. 2009, 36, 341–350. [Google Scholar] [CrossRef] [PubMed]
- Birkenaes, A.B.; Opjordsmoen, S.; Brunborg, C.; Engh, J.A.; Jonsdottir, H.; Ringen, P.A.; Simonsen, C.; Vaskinn, A.; Birkeland, K.I.; Friis, S.; et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: A comparative study. J. Clin. Psychiatry 2007, 68, 917–923. [Google Scholar] [CrossRef] [PubMed]
- Ho, C.S.; Zhang, M.W.; Mak, A.; Ho, R.C. Metabolic syndrome in psychiatry: Advances in understanding and management. Adv. Psychiatr. Treat. 2014, 20, 101–112. [Google Scholar] [CrossRef]
Whole Group | Men | Women | p * | |
---|---|---|---|---|
Age (years) | 58.1 (11.7) | 61.8 (15.7) | 56.9 (12.1) | NS |
Education (years) | 14.3 (7.3) | 13.7 (3.3) | 13.5 (3.1) | NS |
Current smokers (%) | 36.7 | 14.3 | 22.6 | NS |
Living alone (%) | 32 | 14.3 | 17.7 | NS |
BD duration (years) | 23.3 (11) | 30 (18) | 21 (13) | 0.002 1 |
BMI (kg/m2) | 27.6 (5.8) | 27.3 (5.9) | 27.8 (5.1) | NS |
25 < BMI < 30 (%) | 37.6 | 61.9 | 31.1 | 0.01 2 |
BMI ≥ 30 (%) | 22.3 | 14.3 | 32.8 | NS |
Waist circumference (cm) | 93.8 (14) | 96.6 (13.1) | 90.3 (9.3) | NS |
Serum glucose level (mg/dL) | 95.6 (15.4) | 99.8 (22.3) | 94.2 (21.1) | NS |
Serum triglycerides level (mg/dL) | 148.8 (81) | 138.5 | 151.4 | NS |
Insulin (mU/mL) | 11.9 (4) | 10 (6.2) | 12.8 (8.1) | NS |
HOMA-IR | 3.0 (0.3) | 2.7 (0.3) | 3.2 (0.3) | NS |
TyG | 4.7 (0.8) | 4.7 (0.7) | 4.7 (0.9) | NS |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Łojko, D.; Owecki, M.; Suwalska, A. Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management. Int. J. Environ. Res. Public Health 2019, 16, 1132. https://doi.org/10.3390/ijerph16071132
Łojko D, Owecki M, Suwalska A. Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management. International Journal of Environmental Research and Public Health. 2019; 16(7):1132. https://doi.org/10.3390/ijerph16071132
Chicago/Turabian StyleŁojko, Dorota, Maciej Owecki, and Aleksandra Suwalska. 2019. "Impaired Glucose Metabolism in Bipolar Patients: The Role of Psychiatrists in Its Detection and Management" International Journal of Environmental Research and Public Health 16, no. 7: 1132. https://doi.org/10.3390/ijerph16071132